Showing 281 - 300 results of 1,042 for search '"paediatric"', query time: 0.05s Refine Results
  1. 281

    D,L‐3‐hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS) by Aya Amer, Kathryn Murrell, Liza Edmonds, Isaac Bernhardt, Rhonda Akroyd, Bryony Ryder, Callum Wilson, Emma Glamuzina

    Published 2025-01-01
    “…Methods A retrospective case review of patients with Glut1DS under the Adult and Paediatric National Metabolic Service (APNMS) of New Zealand, treated with D,L‐3‐HB between 2012 and 2023 was performed. …”
    Get full text
    Article
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289

    Fracture of the Atlas through a Synchondrosis of Anterior Arch by Gamze Turk, Ismail M. Kabakus, Erhan Akpinar

    Published 2013-01-01
    “…In paediatric cases, most fractures occur through the synchondroses which are the weakest links of the atlas. …”
    Get full text
    Article
  10. 290

    An Extremely Rare Cause of Isolated Congenital Anosmia by Chia Saw, Noel David Friesen, Anthony Bartley

    Published 2022-01-01
    “…A 14-year-old adolescent was referred to a regional paediatric outpatient clinic with anosmia by her family doctor in Western Australia. …”
    Get full text
    Article
  11. 291
  12. 292

    Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection by Giuseppe Indolfi, Elisa Bartolini, Biagio Olivito, Chiara Azzari, Massimo Resti

    Published 2012-01-01
    “…The clinical significance of non-organ specific autoantibodies in the course of paediatric chronic hepatitis C is still debated. Autoantibody positivity can be considered neutral for most patients, while it can be associated with negative connotations for others, especially those positive for liver-kidney microsomal type-1 autoantibody. …”
    Get full text
    Article
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298

    Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry by Prasad T. Oommen, Tilmann Kallinich, Juergen Rech, Norbert Blank, Julia Weber-Arden, Jasmin B. Kuemmerle-Deschner

    Published 2024-12-01
    “…Methods From June 2018, the RELIANCE registry enrolled paediatric (aged ≥ 2 years) and adult patients (aged ≥ 18 years) with MKD/HIDS who were receiving canakinumab as part of their routine medical care. …”
    Get full text
    Article
  19. 299
  20. 300